{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T11:07:01Z","timestamp":1792667221055,"version":"4.5.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.dsx.2021.102210","type":"journal-article","created":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T05:27:36Z","timestamp":1626413256000},"page":"102210","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Association of calcium channel blocker use with clinical outcome of COVID-19: A meta-analysis"],"prefix":"10.1016","volume":"15","author":[{"given":"Mochamad Yusuf","family":"Alsagaff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2681-7743","authenticated-orcid":false,"given":"Eka Prasetya Budi","family":"Mulia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irma","family":"Maghfirah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2160-2927","authenticated-orcid":false,"given":"Kevin","family":"Luke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Nugraha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dita Aulia","family":"Rachmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Imanita","family":"Septianda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5244-3132","authenticated-orcid":false,"given":"Maya Qurota","family":"A'yun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dsx.2021.102210_bib1","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1186\/s12931-020-01479-w","article-title":"From SARS and MERS to COVID-19: a brief summary and comparison of severe acute respiratory infections caused by three highly pathogenic human coronaviruses","volume":"21","author":"Zhu","year":"2020","journal-title":"Respir Res"},{"key":"10.1016\/j.dsx.2021.102210_bib2","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/S2213-2600(20)30116-8","article-title":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?","volume":"8","author":"Fang","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.dsx.2021.102210_bib3","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1001\/jama.2020.5394","article-title":"Baseline characteristics and outcomes of 1591 patients infected with SARS-CoV-2 admitted to ICUs of the lombardy region","volume":"323","author":"Grasselli","year":"2020","journal-title":"Italy. JAMA - J Am Med Assoc"},{"key":"10.1016\/j.dsx.2021.102210_bib4","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"ESC\/ESH Guidelines for the management of arterial hypertension","volume":"39","author":"Williams","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/j.dsx.2021.102210_bib5","first-page":"67","article-title":"New generations of dihydropyridines for treatment of hypertension","volume":"14","author":"Wang","year":"2017","journal-title":"J\u00a0Geriatr Cardiol"},{"key":"10.1016\/j.dsx.2021.102210_bib6","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00426-20","article-title":"Ca 2+ ions promote fusion of Middle East respiratory syndrome coronavirus with host cells and increase infectivity","volume":"94","author":"Straus","year":"2020","journal-title":"J\u00a0Virol"},{"key":"10.1016\/j.dsx.2021.102210_bib7","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.1016\/j.jmb.2017.10.017","article-title":"The SARS-CoV fusion peptide forms an extended bipartite fusion platform that perturbs membrane order in a calcium-dependent manner","volume":"429","author":"Lai","year":"2017","journal-title":"J\u00a0Mol Biol"},{"key":"10.1016\/j.dsx.2021.102210_bib8","article-title":"FDA approved calcium channel blockers inhibit SARS CoV 2 infectivity in epithelial lung cells","author":"Straus","year":"2020","journal-title":"bioRxiv"},{"key":"10.1016\/j.dsx.2021.102210_bib9","article-title":"Nifedipine and amlodipine are associated with improved mortality and decreased risk for intubation and mechanical ventilation in elderly patients hospitalized for COVID-19","volume":"12","author":"Solaimanzadeh","year":"2020","journal-title":"Cureus"},{"key":"10.1016\/j.dsx.2021.102210_bib10","series-title":"Report of the WHO-China joint mission on coronavirus disease 2019 (COVID-19)","author":"World Health Organization","year":"2020"},{"key":"10.1016\/j.dsx.2021.102210_bib11","doi-asserted-by":"crossref","first-page":"3443","DOI":"10.1002\/sim.2380","article-title":"A\u00a0modified test for small-study effects in meta-analyses of controlled trials with binary endpoints","volume":"25","author":"Harbord","year":"2006","journal-title":"Stat Med"},{"key":"10.1016\/j.dsx.2021.102210_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2288-14-135","article-title":"Estimating the sample mean and standard deviation from the sample size, median, range and\/or interquartile range","volume":"14","author":"Wan","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.dsx.2021.102210_bib13","series-title":"Cochrane Handbook for systematic reviews of interventions","author":"Higgins","year":"2019"},{"key":"10.1016\/j.dsx.2021.102210_bib14","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1001\/jamacardio.2020.1624","article-title":"Association of renin-angiotensin system inhibitors with severity or risk of death in patients with hypertension hospitalized for coronavirus disease 2019 (COVID-19) infection in wuhan, China","volume":"5","author":"Li","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.dsx.2021.102210_bib15","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1002\/jmv.26315","article-title":"Efficacy of ACEIs\/ARBs versus CCBs on the progression of COVID-19 patients with hypertension in Wuhan: a hospital-based retrospective cohort study","volume":"93","author":"Liu","year":"2021","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.dsx.2021.102210_bib16","article-title":"Role of drugs used for chronic disease management on susceptibility and severity of COVID-19: a large case-control study","volume":"1\u201332","author":"Yan","year":"2020","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.dsx.2021.102210_bib17","article-title":"Association between renin\u2013angiotensin system inhibitors and COVID-19 complications","volume":"2","author":"Liabeuf","year":"2020","journal-title":"Eur Hear J - Cardiovasc Pharmacother"},{"key":"10.1016\/j.dsx.2021.102210_bib18","first-page":"1","article-title":"Is COVID-19 an endothelial disease? Clinical and basic evidence","volume":"9","author":"Sardu","year":"2020","journal-title":"Clin Basic Evid"},{"key":"10.1016\/j.dsx.2021.102210_bib19","first-page":"1","article-title":"Early clinical factors predicting the development of critical disease in Japanese patients with COVID-19: a single-center, retrospective, observational study","author":"Higuchi","year":"2020","journal-title":"J\u00a0Med Virol"},{"key":"10.1016\/j.dsx.2021.102210_bib20","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.3201\/eid2608.201776","article-title":"Characteristics and outcomes of coronavirus disease patients under nonsurge conditions, Northern California, USA, March\u2013April 2020","volume":"26","author":"Ferguson","year":"2020","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.dsx.2021.102210_bib21","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1001\/jama.2020.11301","article-title":"Association of angiotensin-converting enzyme inhibitor or angiotensin receptor blocker use with COVID-19 diagnosis and mortality","volume":"324","author":"Fosb\u00f8l","year":"2020","journal-title":"JAMA, J Am Med Assoc"},{"key":"10.1016\/j.dsx.2021.102210_bib22","first-page":"1","article-title":"Impaired cardiac function is associated with mortality in patients with acute COVID-19 infection","volume":"14","author":"Rath","year":"2020","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.dsx.2021.102210_bib23","doi-asserted-by":"crossref","first-page":"E10","DOI":"10.1161\/HYPERTENSIONAHA.120.15312","article-title":"Renin-angiotensin-aldosterone system inhibitors and outcome in patients with SARS-CoV-2 pneumonia: a case series study","volume":"76","author":"Conversano","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.dsx.2021.102210_bib24","doi-asserted-by":"crossref","first-page":"104931","DOI":"10.1016\/j.phrs.2020.104931","article-title":"30-day mortality in patients hospitalized with COVID-19 during the first wave of the Italian epidemic: a prospective cohort study","volume":"158","author":"Giacomelli","year":"2020","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.dsx.2021.102210_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0237297","article-title":"Gender differences in predictors of intensive care units admission among COVID-19 patients: the results of the SARS-RAS study of the Italian Society of Hypertension","volume":"15","author":"Iaccarino","year":"2020","journal-title":"PloS One"},{"key":"10.1016\/j.dsx.2021.102210_bib26","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1161\/HYPERTENSIONAHA.120.15324","article-title":"Age and multimorbidity predict death among COVID-19 patients: results of the SARS-RAS study of the Italian society of hypertension","volume":"76","author":"Iaccarino","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.dsx.2021.102210_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3390\/ijerph17145171","article-title":"Baseline chronic comorbidity and mortality in laboratory-confirmed COVID-19 cases: results from the PRECOVID study in Spain","volume":"17","author":"Poblador-Plou","year":"2020","journal-title":"Int J Environ Res Publ Health"},{"key":"10.1016\/j.dsx.2021.102210_bib28","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1080\/10641963.2020.1783549","article-title":"Is the use of ACE inb\/ARBs associated with higher in-hospital mortality in Covid-19 pneumonia patients?","volume":"42","author":"Sel\u00e7uk","year":"2020","journal-title":"Clin Exp Hypertens"},{"issue":"2","key":"10.1016\/j.dsx.2021.102210_bib29","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1590\/1806-9282.66.s2.71","article-title":"Impact of antihypertensive agents on clinical course and in-hospital mortality: analysis of 169 hypertensive patients hospitalized for COVID-19","volume":"66","author":"Kocayigit","year":"2020","journal-title":"Rev Assoc Med Bras"},{"key":"10.1016\/j.dsx.2021.102210_bib30","first-page":"ciaa1459","article-title":"Predictors at admission of mechanical ventilation and death in an observational cohort of adults hospitalized with COVID-19","author":"Jackson","year":"2020","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.dsx.2021.102210_bib31","first-page":"12","article-title":"Renin\u2013angiotensin\u2013aldosterone system inhibitors and risk of death in patients hospitalised with COVID-19: a retrospective Italian cohort study of 43,000 patients","author":"Trifir\u00f2","year":"2020","journal-title":"Drug Saf"},{"key":"10.1016\/j.dsx.2021.102210_bib32","article-title":"Comorbidities for fatal outcome among the COVID-19 patients: a hospital-based case-control study","author":"Lu","year":"2020","journal-title":"J\u00a0Infect"},{"key":"10.1016\/j.dsx.2021.102210_bib33","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1016\/j.jamda.2020.09.004","article-title":"COVID-19 in-hospital mortality and use of renin-angiotensin system blockers in geriatrics patients","volume":"21","author":"Genet","year":"2020","journal-title":"J\u00a0Am Med Dir Assoc"},{"key":"10.1016\/j.dsx.2021.102210_bib34","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1136\/heartjnl-2020-317393","article-title":"Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: cohort study including 8.3 million people","volume":"106","author":"Hippisley-Cox","year":"2020","journal-title":"Heart"},{"key":"10.1016\/j.dsx.2021.102210_bib35","article-title":"Associations of comorbidities and medications with COVID-19 outcome: a retrospective analysis of real-world evidence data","author":"Abu-Jamous","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.dsx.2021.102210_bib36","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.dsx.2020.07.005","article-title":"Association of hypertension, diabetes, stroke, cancer, kidney disease, and high-cholesterol with COVID-19 disease severity and fatality: a systematic review","volume":"14","author":"Zaki","year":"2020","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/j.dsx.2021.102210_bib37","article-title":"Hypertension is associated with increased mortality and severity of disease in COVID-19 pneumonia: a systematic review, meta-analysis and meta-regression","volume":"21","author":"Pranata","year":"2020","journal-title":"JRAAS - J Renin-Angiotensin-Aldosterone Syst"},{"key":"10.1016\/j.dsx.2021.102210_bib38","first-page":"2020","article-title":"Calcium channel blocker amlodipine besylate is associated with reduced case fatality rate of COVID-19 patients with hypertension","author":"Zhang","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.dsx.2021.102210_bib39","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/s41421-020-00221-6","article-title":"Antihypertensive drugs are associated with reduced fatal outcomes and improved clinical characteristics in elderly COVID-19 patients","volume":"6","author":"Yan","year":"2020","journal-title":"Cell Discov"},{"key":"10.1016\/j.dsx.2021.102210_bib40","article-title":"Association between prior calcium channel blocker use and mortality in septic patients: a meta-analysis of cohort studies","author":"Ding","year":"2020","journal-title":"Res Sq"},{"key":"10.1016\/j.dsx.2021.102210_bib41","article-title":"Anti-hypertensive Angiotensin II receptor blockers associated to mitigation of disease severity in elderly COVID-19 patients","author":"Liu","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.dsx.2021.102210_bib42","article-title":"Cardiovascular drugs and COVID-19 clinical outcomes\u00a0: a living systematic review and meta- analysis","author":"Asiimwe","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.dsx.2021.102210_bib43","first-page":"66","article-title":"Calcium channel blocker toxicity causing acute respiratory distress syndrome: a commonly used drug triggering a life-threatening condition","volume":"119","author":"Lodhi","year":"2020","journal-title":"Wis Med J"},{"key":"10.1016\/j.dsx.2021.102210_bib44","first-page":"405","article-title":"Severe pulmonary complications of massive intoxication with calcium channel blockers and isosorbide mononitrate--a case report","volume":"61","author":"Magdalan","year":"2004","journal-title":"Przegl Lek"},{"key":"10.1016\/j.dsx.2021.102210_bib45","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1378\/chest.99.1.258","article-title":"Noncardiogenic pulmonary edema complicating massive diltiazem overdose","volume":"99","author":"Humbert","year":"1991","journal-title":"Chest"},{"key":"10.1016\/j.dsx.2021.102210_bib46","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1053\/j.gastro.2020.05.057","article-title":"Mortality from coronavirus disease 2019 increases with unsaturated fat and may Be reduced by early calcium and albumin supplementation","volume":"159","author":"El-Kurdi","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.dsx.2021.102210_bib47","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1253\/circj.CJ-09-0467","article-title":"Calcium channel blockers differentially modulate cytokine production by peripheral blood mononuclear cells","volume":"74","author":"Matsumori","year":"2010","journal-title":"Circ J"},{"key":"10.1016\/j.dsx.2021.102210_bib48","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.3389\/fimmu.2020.01708","article-title":"Cytokine storm in COVID-19: the current evidence and treatment strategies","volume":"11","author":"Tang","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.dsx.2021.102210_bib49","first-page":"1","article-title":"ESC guidance for the diagnosis and management of CV disease during the COVID-19 pandemic","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.dsx.2021.102210_bib50","first-page":"m1313","article-title":"Calcium channel blockers and the renin-angiotensin system in covid-19, response to: drugs and the renin-angiotensin system in covid-19","volume":"369","author":"Aydin","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/j.dsx.2021.102210_bib51","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1093\/eurheartj\/ehaa331","article-title":"Switching to another antihypertensive effective drug when using ACEIs\/ARBs to treat arterial hypertension during COVID-19","volume":"41","author":"Ciulla","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/j.dsx.2021.102210_bib52","article-title":"Renin-Angiotensin-Aldosterone-System inhibitor use in patients with COVID-19 infection and prevention of serious events: a cohort study in commercially insured patients in the US","author":"Schneeweiss","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.dsx.2021.102210_bib53","series-title":"Clinical characteristics of coronavirus disease 2019 in hainan, China","author":"Yan","year":"2020"},{"key":"10.1016\/j.dsx.2021.102210_bib54","article-title":"Characteristics and predictors of hospitalization and death in the first 9,519 cases with a positive RT-PCR test for SARS-CoV-2 in Denmark: a nationwide cohort","author":"Reilev","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.dsx.2021.102210_bib55","article-title":"Impact of hypertension on progression and prognosis in patients with COVID-19: a retrospective cohort study in 1031 hospitalized cases in wuhan, China","author":"Zeng","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.dsx.2021.102210_bib56","article-title":"Clinical characteristics and severity of COVID-19 disease in patients from boston area hospitals","author":"Dashti","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/j.dsx.2021.102210_bib57","article-title":"Antihypertensive medications and COVID-19 diagnosis and mortality: population-based case-control analysis in the United Kingdom","author":"Rezel-Potts","year":"2020","journal-title":"medRxiv"}],"container-title":["Diabetes & Metabolic Syndrome: Clinical Research & Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402121002307?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1871402121002307?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T09:16:59Z","timestamp":1761729419000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1871402121002307"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":57,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S1871402121002307"],"URL":"https:\/\/doi.org\/10.1016\/j.dsx.2021.102210","relation":{},"ISSN":["1871-4021"],"issn-type":[{"value":"1871-4021","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of calcium channel blocker use with clinical outcome of COVID-19: A meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Diabetes & Metabolic Syndrome: Clinical Research & Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dsx.2021.102210","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Diabetes India. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102210"}}